--- title: "First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform" type: "News" locale: "en" url: "https://longbridge.com/en/news/282741842.md" datetime: "2026-04-14T20:32:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282741842.md) - [en](https://longbridge.com/en/news/282741842.md) - [zh-HK](https://longbridge.com/zh-HK/news/282741842.md) --- # First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform April 14 (Reuters) - Cabaletta Bio Inc (CABA.O) : \* FIRST PATIENTS DOSED WITH CABALETTA BIO’S RESE-CEL MANUFACTURED ON CELLARES' AUTOMATED CELL SHUTTLE™ PLATFORM Source text: Further company coverage: (CABA.O) ### Related Stocks - [CABA.US](https://longbridge.com/en/quote/CABA.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) ## Related News & Research - [BUZZ-Allogene tumbles on $175 mln stock offering after cancer therapy data](https://longbridge.com/en/news/282722450.md) - [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md) - [ZAWYA: CE-Ventures announces acquisition of portfolio company CrossBridge Bio by Eli Lilly](https://longbridge.com/en/news/282695762.md) - [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md) - [](https://longbridge.com/en/news/282567251.md)